BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rapamycin
,
rs3825942
,
GATA1
,
G-protein-coupled receptor binding
,
Obesity
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of phospholipase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Eosinophil of peripheral blood
Conjunctiva
Oral mucosa
Testes
Tongue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of phospholipase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral …
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer
The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome
PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Usin…
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ